Rubinstein A - Search Results

1

Phosphated crosslinked guar for colon-specific drug delivery. I. Preparation and physicochemical characterization.

Gliko-Kabir I, Yagen B, Penhasi A, Rubinstein A. Gliko-Kabir I, et al. Among authors: rubinstein a. J Control Release. 2000 Jan 3;63(1-2):121-7. doi: 10.1016/s0168-3659(99)00179-0. J Control Release. 2000. PMID: 10640585

2

Low swelling, crosslinked guar and its potential use as colon-specific drug carrier.

Gliko-Kabir I, Yagen B, Penhasi A, Rubinstein A. Gliko-Kabir I, et al. Among authors: rubinstein a. Pharm Res. 1998 Jul;15(7):1019-25. doi: 10.1023/a:1011921925745. Pharm Res. 1998. PMID: 9688054

3

Phosphated crosslinked guar for colon-specific drug delivery. II. In vitro and in vivo evaluation in the rat.

Gliko-Kabir I, Yagen B, Baluom M, Rubinstein A. Gliko-Kabir I, et al. Among authors: rubinstein a. J Control Release. 2000 Jan 3;63(1-2):129-34. doi: 10.1016/s0168-3659(99)00180-7. J Control Release. 2000. PMID: 10640586

4

The use of scintigraphy to provide "proof of concept" for novel polysaccharide preparations designed for colonic drug delivery.

Adkin DA, Kenyon CJ, Lerner EI, Landau I, Strauss E, Caron D, Penhasi A, Rubinstein A, Wilding IR. Adkin DA, et al. Among authors: rubinstein a. Pharm Res. 1997 Jan;14(1):103-7. doi: 10.1023/a:1012019820603. Pharm Res. 1997. PMID: 9034229 Clinical Trial.

5

Crosslinked chitosan implants as potential degradable devices for brachytherapy: in vitro and in vivo analysis.

Azab AK, Orkin B, Doviner V, Nissan A, Klein M, Srebnik M, Rubinstein A. Azab AK, et al. Among authors: rubinstein a. J Control Release. 2006 Apr 10;111(3):281-9. doi: 10.1016/j.jconrel.2005.12.014. Epub 2006 Feb 24. J Control Release. 2006. PMID: 16499987

6

Improved intestinal absorption of sulpiride in rats with synchronized oral delivery systems.

Baluom M, Friedman M, Rubinstein A. Baluom M, et al. Among authors: rubinstein a. J Control Release. 2001 Jan 29;70(1-2):139-47. doi: 10.1016/s0168-3659(00)00337-0. J Control Release. 2001. PMID: 11166414

7

Approaches and opportunities in colon-specific drug delivery.

Rubinstein A. Rubinstein A. Crit Rev Ther Drug Carrier Syst. 1995;12(2-3):101-49. doi: 10.1615/critrevtherdrugcarriersyst.v12.i2-3.10. Crit Rev Ther Drug Carrier Syst. 1995. PMID: 9501968 Review.

8

Cross-linked chondroitin sulphate: characterization for drug delivery purposes.

Sintov A, Di-Capua N, Rubinstein A. Sintov A, et al. Among authors: rubinstein a. Biomaterials. 1995 Apr;16(6):473-8. doi: 10.1016/0142-9612(95)98820-5. Biomaterials. 1995. PMID: 7654874

9

Targeting normal and neoplastic tissues in the rat jejunum and colon with boronated, cationic acrylamide copolymers.

Azab AK, Srebnik M, Doviner V, Rubinstein A. Azab AK, et al. Among authors: rubinstein a. J Control Release. 2005 Aug 18;106(1-2):14-25. doi: 10.1016/j.jconrel.2005.03.015. J Control Release. 2005. PMID: 16005094

10

Prevention of tumor recurrence and distant metastasis formation in a breast cancer mouse model by biodegradable implant of 131I-norcholesterol.

Azab AK, Kleinstern J, Doviner V, Orkin B, Srebnik M, Nissan A, Rubinstein A. Azab AK, et al. Among authors: rubinstein a. J Control Release. 2007 Nov 6;123(2):116-22. doi: 10.1016/j.jconrel.2007.07.014. Epub 2007 Aug 8. J Control Release. 2007. PMID: 17854940

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

731 results

Search Page

Filters